Moreover, we provide data to show poor clinical outcomes in breast cancer patients with exceedingly high CD8+ TC/IM ratios, which were associated with increased frequencies of CD163+ and FoxP3+ cells. The gene discussed is CD8A; the disease is breast cancer.